← All indications
Back Pain
Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.
Subtype terms (2)
More specific conditions that are subtypes of Back Pain in the MeSH hierarchy.
- Failed Back Surgery Syndrome
8 drugs (6 approved, 2 experimental)
- Low Back Pain
145 drugs (91 approved, 54 experimental)
Drugs by status
Approved for this indication (14)
Phase 4 trials (37)
- diclofenac
- procaine benzylpenicillin
- ketamine
- clavulanate
- oxycodone
- betamethasone
- duloxetine
- parathyroid hormone
- ginger
- glucosamine
- haloperidol
- histamine
- ozone
- ketorolac
- platelet-rich plasma
- rimabotulinumtoxinB
- alendronic acid
- celecoxib
- buprenorphine
- bupivacaine
- tramadol
- fentanyl
- methadone
- avocado
- iodixanol
- morphine
- naloxone
- pregabalin
- soybean
- sodium chloride
- +7 more
Phase 3 trials (29)
- melatonin
- hydrocodone
- propofol
- methylprednisolone
- human fibrin
- bicifadine
- cyclobenzaprine
- cannabidiol
- sevoflurane
- famotidine
- hwangryun
- eperisone
- pelubiprofen
- caffeine
- teriparatide
- tizanidine
- fasinumab
- rocuronium
- levobupivacaine
- sinbaro-3
- cannabis
- risedronate
- sufentanil
- tetrahydrocannabinol
- hydromorphone
- esomeprazole
- milnacipran
- ergocalciferol
- dextrose
Phase 2 trials (41)
- allostim
- asp7962
- bee venom
- benzatropine
- loratadine
- dehydroepiandrosterone
- axomadol
- gabapentin
- naltrexone
- gonyautoxin
- bone marrow derived mesenchymal stem cells
- levodopa
- carbidopa
- loxoprofen
- fluoxetine
- ly3016859
- pamidronate
- pf-06372865
- propranolol
- arbaclofen
- tolperisone
- estradiol
- testosterone
- cellulose
- zolpidem
- autologous bone marrow derived mesenchymal cells
- modafinil
- psilocybin
- minocycline
- nortriptyline
- +11 more
Phase 1 trials (10)
Other trials (28)
- vitamin d3
- urea
- paroxetine
- citalopram
- sertraline
- guaifenesin
- lavender
- ropivacaine
- donepezil
- hyaluronic acid
- clonidine
- trazodone
- osteocel
- autologous stromal vascular fraction
- stromal vascular fraction
- almond
- autologous mesenchymal stem cells
- triamcinolone
- midazolam
- copaiba
- rose oil
- maprotiline
- fish oil
- water
- cayenne pepper
- amniotic and umbilical cord matrix
- zhineng qigong
- yanqing zhitong
Organizations
Organization Involved with Phase 4 Indications (90)
- Ferrosan AS
- Napo Pharmaceuticals
- Grunenthal
- Merck
- Eli Lilly
- Pfizer
- Sanofi
- Endo Pharmaceuticals
- Mallinckrodt
- Mundipharma
- Nycomed
- Targeted Medical Pharma
- Sunovion
- Fundação Educacional Serra dos Órgãos
- National Institutes of Health (NIH)
- Azienda Sanitaria Locale 4, Teramo
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute of General Medical Sciences (NIGMS)
- National Institute on Drug Abuse (NIDA)
- United States Army
- United States Air Force
- University of Pittsburgh
- Akdeniz University
- Celal Bayar University
- Harvard University
- Duke University
- Gachon University
- University of Washington
- Grupo Rehabilitacion en Salud
- +60 more
Organization Involved with Phase 3 Indications (87)
- Abbott
- AbbVie
- Meda
- Regeneron
- Ache Laboratorios Farmaceuticos S.A.
- Horizon Pharma
- Eisai
- Takeda
- Labopharm
- Cephalon
- Bausch Health Companies
- Forest Laboratories
- Shionogi
- Alza
- Ipsen
- Purdue Pharmaceuticals
- Bayer
- BioDelivery Sciences International
- Braeburn Pharmaceuticals
- DOV Pharmaceutical, Inc.
- Farmoquimica S.A.
- Merz
- Nektar Therapeutics
- Spinal Restoration, Inc.
- Teva
- VanWorld Pharmaceutical (Rugao) Company Limited
- Boehringer Ingelheim
- Collegium Pharmaceutical, Inc.
- Daewon Pharmaceutical Co., Ltd.
- Navipharm Corporation
- +57 more
Organization Involved with Phase 2 Indications (43)
- Astellas
- Novartis
- Allodynic Therapeutics, LLC
- CHABiotech CO., Ltd
- Indena S.p.A
- Indivior Inc.
- Red de Terapia Celular
- Teikoku Pharma USA, Inc.
- Durect
- Frontier Biotechnologies Co., Ltd.
- Stayble Therapeutics
- National Institute of Neurological Disorders and Stroke (NINDS)
- Smigel, Liza, M.D.
- Ardabil University of Medical Sciences
- Azad University
- Hospital de Egas Moniz
- Inje University
- Kyung Hee University
- McGill University
- Rijnstate Hospital
- University of Miami
- University of Oulu
- Yale University
- Wenzhou Medical University
- University of California, San Diego
- Icahn School of Medicine at Mount Sinai
- Istanbul Medipol University
- Wilhelminenspital der Stadt Wien
- Abecma
- Hanmi Pharmaceutical
- +13 more
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (47)
- Allergan
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- J.A.R. Laboratories
- Tissue Tech Inc.
- National Institute of Mental Health (NIMH)
- Ataturk University
- Case Western Reserve University
- Chang Gung University
- Cornell University
- Dartmouth University
- Hillel Yaffe Medical Center
- Johns Hopkins University
- Korea Institute of Oriental Medicine
- Palo Alto Veterans Institute for Research
- Postgraduate Institute of Medical Education and Research
- Sundsvall Hospital
- Universidad Autónoma Benito Juárez de Oaxaca
- University of Seville
- University of Southern California
- University of Thessaly
- University of Toronto
- University of Alberta
- University of Athens
- Wake Forest University
- West Virginia University
- Assiut University
- Group Health Cooperative
- Istanbul University
- Stony Brook University
- +17 more